The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...
Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.
Maintenance of vascular access has long been the Achilles’ heel of patients undergoing hemodialysis (HD). Evolving from the direct cannulation of native vessels to highly morbid Teflon shunts, it wasn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results